Print

AVEG 004A

Trial Details:

I Completed
National Institute of Allergy and Infectious Diseases (NIAID) August 04, 1992
gp160 Vaccine (Immuno-AG) Protein gp160 env B LAI, MN
gp160 Vaccine (Immuno-AG) Protein
USA 25
NCT00001056
http://clinicaltrials.gov/ct2/show/NCT00001056